Bibliometric Analysis and Visualization of Clinical Trials on the Therapeutic Potential of Essential Oils (1967-2024)Public Health Published on 2024-04-012024-09-05 Journal: Cureus [Category] update2024, [키워드] aetheroleum antimicrobial anxiolytic Bibliometric Dental health ethereal oils mental health minor tranquillizer network analysis scientometric analysis [DOI] 10.7759/cureus.57430 PMC 바로가기 [Article Type] Public Health
Shedding light on the toxicity of SARS-CoV-2-derived peptide in non-target COVID-19 organisms: A study involving inbred and outbred mice비표적 COVID-19 유기체에서 SARS-CoV-2 유래 펩타이드의 독성에 대한 조명: 근친교배 및 근친교배 마우스를 대상으로 한 연구Article Published on 2022-05-012022-09-11 Journal: Neurotoxicology [Category] COVID19(2023년), MERS, SARS, 바이오마커, 유전자 메커니즘, [키워드] acetylcholinesterase activated administration alteration animals antidepressant antioxidant anxiolytic applied biochemical Biomarker Brain C57Bl/6 J mice catalase consequence COVID-19 demonstrated depressive dismutase dispersion Effect Environmental Toxicology evaluate evaluated Evidence evidence of exposure to Field test genetic profile greater homeostasis hydrogen hydrogen peroxide Impact Laboratory locomotor maintain male mammalian mechanism memory memory deficit mice natural environments open oxidative stress Pandemic COVID-19 PCA peptide Principal component principal component analysis Protein Proteins provide reactive reduction in Research response SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 particle SARS-CoV-2 particles sensitivity shedding Spike protein Superoxide Superoxide Dismutase Swiss mice. the Spike the vaccine Therapeutic strategies therapeutic strategy Toxicity Viral [DOI] 10.1016/j.neuro.2022.03.012 PMC 바로가기 [Article Type] Article
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †COVID-19에서 보조 약물로 칸나비디올을 사용할 때의 기회, 도전 및 함정 †Review Published on 2021-02-172022-09-10 Journal: International Journal of Molecular Sciences [Category] 치료제, [키워드] ACE2 acting acute respiratory syndrome acute respiratory syndrome coronavirus adjuvant administration antinociceptive anxiolytic cannabidiol cannabis challenge Clinical studies clinical study coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demonstrated disadvantage Disadvantages disease diseases of the respiratory system downregulate drug drug interaction Drug interactions Effect Effectiveness IMPROVE Infection inhibit SARS-CoV-2 lead life limit multiple organ dysfunction organ dysfunction patients with COVID-19 Post-traumatic stress symptoms preclinical studies preclinical study Protein Quality of life Replication respiratory Respiratory disease Respiratory system responsible SARS-CoV-2 SARS-CoV-2 replication severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 shown Side effect Side effects Treatment treatment of COVID-19 turn Viral viral entry [DOI] 10.3390/ijms22041986 PMC 바로가기 [Article Type] Review